Martin J. Duvall

Martin J. Duvall

Chairman bij Oncopeptides, Inc.

62 jaar
Health Technology
Consumer Services
Health Services

Profiel

Presently, Martin J.
Duvall
is Chairman for Oncopeptides, Inc. He is also on the board of Oncopeptides Incentive AB and Senior Vice President-Commercial Operations at MGI PHARMA Biologics, Inc. Mr. Duvall previously held the position of Chief Executive Officer of Oncopeptides AB, Senior Vice President & General Manager at Merck & Co., Inc., Chief Executive Officer & Director at Tocagen, Inc., Senior Vice President-Commercial Operations at MGI PHARMA, Inc., Chief Commercial Officer & Executive VP of ARIAD Pharmaceuticals, Inc., Vice President for Aventis Pharmaceuticals, Inc. and Senior Vice President-Global Marketing at Abraxis BioScience, Inc. He received an undergraduate degree from Muhlenberg College, a graduate degree from The Johns Hopkins University and an MBA from the University of Kansas.

Actieve functies van Martin J. Duvall

BedrijvenFunctieBegin
Corporate Officer/Principal 01-11-2004
Chairman -
Oncopeptides Incentive AB Director/Board Member -
Alle actieve functies van Martin J. Duvall

Eerdere bekende functies van Martin J. Duvall

BedrijvenFunctieEinde
ONCOPEPTIDES AB Chief Executive Officer 15-11-2021
FORTE BIOSCIENCES, INC. Chief Executive Officer 15-06-2020
ARIAD PHARMACEUTICALS, INC. Corporate Officer/Principal 26-05-2016
MERCK & CO., INC. Corporate Officer/Principal 01-09-2011
Corporate Officer/Principal 27-04-2011
Ervaring van Martin J. Duvall in detail bekijken

Opleiding van Martin J. Duvall

The Johns Hopkins University Graduate Degree
Muhlenberg College Undergraduate Degree
University of Kansas Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Martin J. Duvall in detail bekijken

Connecties

100 +

Eerstegraads connecties

13

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
MERCK & CO., INC.

Health Technology

ONCOPEPTIDES AB

Health Technology

Bedrijven in privébezit8

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Oncopeptides Incentive AB

Health Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Martin J. Duvall